UTC Investment

Rznomics is a biotechnology company founded by professor Lee Sung-wook's lab, focusing on the development of innovative gene therapy products aimed at treating liver cancer and other serious medical conditions. The company specializes in ribonucleic acid-based therapies that address significant unmet medical needs, particularly in the areas of cancer, degenerative neurological disorders, and hereditary diseases. By creating new biopharmaceuticals, Rznomics aims to provide medical practitioners with effective treatment options for challenging health issues, including various types of cancer and Alzheimer’s disease. The company has garnered recognition for its technological excellence, having been selected for the TIPS program, which highlights its commitment to advancing medical science.

Creatz is a sports consulting online platform based on artificially generated data.

PDC*line Pharma is a clinical-stage biotech company based in France and Belgium, focused on developing innovative active immunotherapies for cancer. The company specializes in a proprietary allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line), which are loaded with cancer-specific antigens to stimulate a robust immune response. Founded in April 2014 in Grenoble by Laurent Levy and Joel Plumas, the company emerged from a research program at the French Blood Bank that developed the PDC line from a patient with PDC leukemia. PDC*line Pharma aims to enhance cancer treatment efficacy by producing potent and scalable PDC lines that can boost antitumor responses, including the activation of neoantigens and specific cytotoxic T-cells, offering a more effective alternative to conventional vaccines.

Provider of medical device development and commercialization services intended to offer new medical devices for advanced treatments and diagnoses. The company's service offerings include diagnosis of medical device ideas, prototype production, patents, national projects, empirical research, preclinical research, prototype development, technology transfer and product launch, enabling the smooth commercialization of startups with medical device ideas.

Operator of a biotechnology company intended to provide drug discovery pipelines to treat diseases. The company develops high-quality iPSC-derived cell products through embryonic stem cell technology, enabling clients to conquer unmet medical needs and iPSC technology

Localstitch, founded in 2013 and based in South Korea, operates as a provider of shared office and residential spaces. The company aims to create environments where individuals can live, work, and launch businesses. By designing and managing flexible spaces, Localstitch facilitates collaboration among professionals while offering affordable rates that alleviate the financial burdens often associated with urban living. This approach allows clients to concentrate on their creative endeavors in a supportive community setting.

SecuLetter Co., Ltd. is a South Korean company that specializes in developing and marketing cybersecurity solutions aimed at detecting and mitigating unknown cyber threats. Founded in 2015 and based in Seongnam-si, the company offers advanced products such as SecuLetter Email, which protects against email-based attacks using malicious code, and SecuLetter FileServer, designed to secure file servers against threats from malicious attachments. SecuLetter employs a hybrid approach that combines static and dynamic analyses to effectively identify and counteract sophisticated cyber attacks, including malware and phishing attempts. The company focuses on various sectors, including email security, data transmission, web service security, document centralization, and cloud security, providing comprehensive protection against evolving cyber threats.

PDC*line Pharma is a clinical-stage biotech company based in France and Belgium, focused on developing innovative active immunotherapies for cancer. The company specializes in a proprietary allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line), which are loaded with cancer-specific antigens to stimulate a robust immune response. Founded in April 2014 in Grenoble by Laurent Levy and Joel Plumas, the company emerged from a research program at the French Blood Bank that developed the PDC line from a patient with PDC leukemia. PDC*line Pharma aims to enhance cancer treatment efficacy by producing potent and scalable PDC lines that can boost antitumor responses, including the activation of neoantigens and specific cytotoxic T-cells, offering a more effective alternative to conventional vaccines.

Operator of a brand commerce platform intended to build and promote brands. The company works in various food and beverage franchises and sells home meal replacement (HMR) products and acts as a distributor and seller of business-to-business-to-consumer (B2B2C) products through various on-off channels, providing customers with multiple products under a single platform.

Localstitch, founded in 2013 and based in South Korea, operates as a provider of shared office and residential spaces. The company aims to create environments where individuals can live, work, and launch businesses. By designing and managing flexible spaces, Localstitch facilitates collaboration among professionals while offering affordable rates that alleviate the financial burdens often associated with urban living. This approach allows clients to concentrate on their creative endeavors in a supportive community setting.

LOGISPOT Co., Ltd. provides inland freight transportation services to companies ranging from large enterprises to small and medium enterprises (SMEs) in South Korea. The company was founded in 2016 and is based in Seoul, South Korea.

Oncorus, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative viral immunotherapies for cancer treatment. The company's lead candidate, ONCR-177, utilizes an oncolytic herpes simplex virus type 1 platform and is currently in Phase I clinical trials aimed at treating various cancers. In addition to ONCR-177, Oncorus is advancing the ONCR-GBM program for brain cancer and exploring synthetic viral immunotherapies based on Coxsackievirus A21 and Seneca Valley Virus. The company has entered a collaboration with MSD International GmbH to evaluate the safety and tolerability of ONCR-177 in combination with Merck’s immunotherapy. Founded in 2015 and headquartered in Cambridge, Massachusetts, Oncorus is committed to advancing cancer care and has pledged to support cancer research and healthcare initiatives in developing regions through corporate philanthropy.

I-ON Digital Corp. engages in the development and supply of unstructured data management and digital marketing software and solutions in South Korea and Japan. It offers enterprise content management system and digital experience solutions, such as I-ON Content Server, I-ON Content Application Framework Engine, I-ON Deploy Server, I-ON Content Ecosystem, I-ON Digital Asset Management System, and I-ON Web Analytics Server; and sports and IT convergence service and solutions, which include Ticket Advanced Marketing Management, a mobile business to business to consumer platform that integrates and manages the professional sports events, as well as VoiceBall, an amateur league umpire and data service. The company also provides software as a service solutions, which include GAIA, a distributed repository service; iDrive, an e-document management system; e.Form, a mobile contract platform; and Assist9, a mobile enterprise resource planning dashboard. In addition, it offers energy management solutions comprising Load Aggregator’s Management System, a demand response management solution designed to manage and reduce electricity consumption. The company was formerly known as I-ON Communications Corp. I-ON Digital Corp. was founded in 1999 and is headquartered in Seoul, South Korea.

Woman’s Talk is viewed by its users as a ‘friendly’ platform for the way in which it provides users with pricing and product related information. A key factor in the success of the business is the requirement for product brands to provide their most competitive price and product guarantee. Woman’s Talk in return provides a lower service fee compared to traditional distribution services whilst also providing the full marketing support required to promote the product.

VNPT Electronic Payment JSC provides electronic payment services. It offers payment solutions, such as card charging, SMS, and Megabank services; top-up services for recharging in games and phones; E-wallet services; and MegaCard.vn, an online service portal for supporting the gaming community. The company is based in Hanoi, Vietnam.